(Q92779921)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

title

Development and optimization of OspC chimeritope vaccinogens for Lyme disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

Jerilyn R Izac

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Nathaniel S O'Bier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Lee D Oliver

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Andrew C Camire

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Christopher G Earnhart

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

DeLacy V LeBlanc Rhodes

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Brandon F Young

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Stuart R Parnham

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Christopher Davies

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Richard T Marconi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

publication date

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

1915-1924

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31959423%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology of Lyme disease

1 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Spirochetes Isolated from the Blood of Two Patients with Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Lyme disease-a tick-borne spirochetosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Identification of a third genomic group of Borrelia burgdorferi through signature nucleotide analysis and 16S rRNA sequence determination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Phylogenetic analysis of the genus Borrelia: a comparison of North American and European isolates of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Conspecificity of the ticks Ixodes scapularis and I. dammini (Acari: Ixodidae).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Impacts of an introduced forest pathogen on the risk of Lyme disease in California

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

A clear and present danger: tick-borne diseases in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005-2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Lyme borreliosis in dogs and humans in the USA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

ACVIM consensus update on Lyme borreliosis in dogs and cats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Stage-specific global alterations in the transcriptomes of Lyme disease spirochetes during tick feeding and following mammalian host adaptation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

[Death of a vaccine--the fall of LYMErix]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Multicomponent Lyme vaccine: three is not a crowd

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

A DNA vaccine encoding the outer surface protein C from Borrelia burgdorferi is able to induce protective immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Borreliacidal antibody production against outer surface protein C of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Development of an OspC-based tetravalent, recombinant, chimeric vaccinogen that elicits bactericidal antibody against diverse Lyme disease spirochete strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Identification of Borrelia burgdorferi ospC genotypes in canine tissue following tick infestation: implications for Lyme disease vaccine and diagnostic assay design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Antibody profiling of canine IgG responses to the OspC protein of the Lyme disease spirochetes supports a multivalent approach in vaccine and diagnostic assay development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Role of the N-terminal activation domain of the coiled-coil coactivator in mediating transcriptional activation by beta-catenin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Evidence for the contribution of point mutations to vlsE variation and for apparent constraints on the net accumulation of sequence changes in vlsE during infection with Lyme disease spirochetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Identification of residues within ligand-binding domain 1 (LBD1) of the Borrelia burgdorferi OspC protein required for function in the mammalian environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Identification of a defined linear epitope in the OspA protein of the Lyme disease spirochetes that elicits bactericidal antibody responses: Implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Structure of Factor H-binding Protein B (FhbB) of the Periopathogen,Treponema denticola

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Rapid clearance of Lyme disease spirochetes lacking OspC from skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

An Octavalent Lyme Disease Vaccine Induces Antibodies That Recognize All Incorporated ospC Type-Specific Sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Antibodies to loop 6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Investigation of ospC Expression Variation among Borrelia burgdorferi Strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Borreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Invasive potential of Borrelia burgdorferi sensu stricto ospC type L strains increases the possible disease risk to humans in the regions of their distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027

inferred from DOI database lookup

7 January 2021

based on heuristic

Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2020.01.027